Bank Julius Baer & Co. Ltd, Zurich Guardant Health, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$48.25 - $100.49 $78,165 - $162,793	-1,620 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$88.71 - $120.43 $55,000 - $74,666	620 Added 62.0%	1,620 $162,000
Q3 2021 Nov 12, 2021	SELL	$98.77 - $132.17 $29,235 - $39,122	-296 Reduced 22.84%	1,000 $125,000
Q2 2021 Jul 23, 2021	BUY	$109.77 - $165.68 $32,491 - $49,041	296 Added 29.6%	1,296 $161,000
Q1 2021 May 10, 2021	SELL	$127.04 - $179.1 $9.63 Million - $13.6 Million	-75,831 Reduced 98.7%	1,000 $153,000
Q4 2020 Feb 24, 2021	BUY	$99.96 - $135.93 $1.62 Million - $2.21 Million	16,244 Added 26.81%	76,831 $9.9 Million
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $1.42 Million - $1.93 Million	14,210 Added 30.64%	60,587 $9.9 Million
Q3 2020 Nov 10, 2020	BUY	$80.32 - $111.8 $1.28 Million - $1.78 Million	15,896 Added 52.15%	46,377 $5.18 Million
Q2 2020 Aug 12, 2020	SELL	$60.49 - $97.5 $360,822 - $581,587	-5,965 Reduced 16.37%	30,481 $2.46 Million
Q1 2020 May 13, 2020	BUY	$59.04 - $88.81 $2.15 Million - $3.24 Million	36,446 New	36,446 $2.53 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.